Search Results
Results found for "custom ligand development"
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
This applied article walks through ligand-directed labeling, SNAP/Halo tags, and fluorescent ligands Physiological relevance: Fluorescent ligands can retain receptor integrity—critical when signaling readouts
- Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools
Developed to address long-standing challenges in GPCR internalization assays , pHSense™ reagents combine Eric Trinquet, Director of Research and Development at Revvity. GPCR Internalization Tool Designed for Real Research Needs s of GPCR assay innovation , pHSense™ was developed addition to Revvity’s GPCR reagent portfolio , which supports every stage of the signaling cascade: GPCR ligand its application in real-time internalization assays and the scientific “aha” moments that drove its development
- From Ox Liver to AI: How the History of Pharmacology Shapes Its Future
Fast-forward a few thousand years, and we’re talking beta receptors, receptor theory, and AI-generated ligands
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
muscarinic receptors for the treatment of alcohol use disorders: Opportunities and hurdles for clinical development treatment through network pharmacology and molecular docking The Effect of Cancer-Associated Mutations on Ligand Case for the 5-HT2C Receptor Reviews, GPCRs, and more Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors Ligand bias at the muscarinic acetylcholine receptor family: Opportunities muscarinic receptors for the treatment of alcohol use disorders: Opportunities and hurdles for clinical development
- From Multiplex to Models: Scaling Up GPCR Discovery in the Post-Silo Era
(e.g., 14-3-3) Heterodimerization Endogenous vs. overexpressed systems Orphan GPCR deorphanization Ligand
- Antibodies That Don’t Block, They Activate: A New Angle on Autoimmunity and GPCRs
sees a future where this system is not just used for detection, but for functional screening : add ligands
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
therapy Rational design of highly stabilized and selective adrenomedullin analogs Novel multi-target ligands scaffolds-synthesis, biological activity, and structural evaluation Flavonoids as G Protein-coupled Receptors Ligands Annual Meeting March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating
- 📰 GPCR Weekly News, March 25 to March 31, 2024
Hoare's workshop for individuals who live and work in developing countries. receptor Computational modelling of dynamic cAMP responses to GPCR agonists for exploration of GLP-1R ligand and exerting BRL37344-like effects on mouse metabolism Mechanistic insights into sodium ion-mediated ligand binding affinity and modulation of 5-HT2B GPCR activity: implications for drug discovery and development VMAT2 Inhibitor, in Healthy Adults Confo Therapeutics Secures VLAIO Grant Supporting Drug Discovery & Development
- Structural insights into adhesion GPCR ADGRL3 activation and Gq, Gs, Gi, and G12 coupling
is the removal of the inhibitory GAIN domain and the dipping of the cleaved stalk peptide into the ligand-binding The structures reveal unique ligand-engaging mode, distinctive activation conformation, and key mechanisms
- 📰 GPCR Weekly News, February 12 to 18, 2024
Drugs, and more Nanobody-Mediated Dualsteric Engagement of the Angiotensin Receptor Broadens Biased Ligand impacts on metabolism of polyamines, mRNA splicing, regulation of RAS by GAPs, neddylation and GPCR ligand in Pharmacology and Drug Discovery March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating
- Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...
employed optical assays in living cells to thoroughly profile both GPR35 isoforms for constitutive and ligand-induced activation and signaling of 10 different heterotrimeric G proteins, ligand-induced arrestin recruitment and mechanistic insights of our study provide clues for the future design of isoform-specific GPR35 ligands
- 📰 GPCR Weekly News, March 6 to 12, 2023
Novel Xanomeline-Containing Bitopic Ligands of Muscarinic Acetylcholine Receptors: Design, Synthesis Molecular sensing of mechano- and ligand-dependent adhesion GPCR dissociation. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. Studentship - Integrated Approaches In Pharmacology, Computer Simulations And Machine Learning To Predict Ligand
- GPR110, a receptor for synaptamide, expressed in osteoclasts negatively regulates osteoclastogenesis
Synaptamide suppressed osteoclastogenesis induced by receptor activator of nuclear factor-kappa B ligand Our study suggested that ligands of GPR110, such as synaptamide, might be a useful drug for osteoporotic
- Neurotransmitters: Potential Targets in Glioblastoma
Significantly, many ligands acting on neurotransmitter receptors have shown great potential for inhibiting GBM growth and development, requiring further research.
- Interacting binding insights and conformational consequences of the differential activity of...
dual contrasting functional feature of CBD, that is, displaying antagonistic and (possible) agonistic ligand From microsecond-length unbiased molecular dynamics simulations, we found that the presence of the CBD ligand These results are in agreement with the proposed modulatory function of each ligand, showing that the In contrast to the CBD/CB1 complex, when the CB1 receptor is simulated in complex with the ligand antagonist
- 📰 GPCR Weekly News, January 15 to 21, 2024
GPCR GPR116/ADGRF5 has a dual function in pancreatic islets regulating somatostatin release and islet development Gq-Signaling Inhibitor FR900359 Derived From Unculturable Plant Symbiont Systematic assessment of chemokine ligand 2024 | 2024 BPS Annual Meeting NEW March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating
- Multifunctional role of GPCR signaling in epithelial tube formation
During Drosophila embryonic salivary gland (SG) invagination, the GPCR ligand Folded gastrulation (Fog Our data support a model wherein Smog regulates distinct myosin pools and actin cytoskeleton in a ligand-dependent
- Functional Characterization of the Venus Flytrap Domain of the Human TAS1R2 Sweet Taste Receptor
Ligand binding quantified by intrinsic tryptophan fluorescence showed that hTAS1R2-VFT is capable of have deleterious effects on cellular assays, could impact the ability of hTAS1R2-VFT to bind sweet ligands As expected, the ligand affinities of hTAS1R2-VFT were drastically reduced through the introduction of
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
Sexton , Denise Wootten , et al., for their work on Isoquinoline small molecule ligands are agonists Positive Allosteric Modulators Enabling Optical Control of the M1 Receptor Isoquinoline small molecule ligands Insights into GPCR Function Monitoring GPCR conformation with GFP-inspired dyes Structural basis for the ligand
- 📰 GPCR Weekly News, December 11 to 17, 2023
Ross Cheloha's research involves semi-synthetic nanobody-ligand conjugates with enhanced transcriptional complex unravels the biased signaling mechanism GPCR Binders, Drugs, and more Semi-synthetic nanobody-ligand Annual Meeting March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating
- Multifunctional role of GPCR signaling in epithelial tube formation
During Drosophila embryonic salivary gland (SG) invagination, the GPCR ligand Folded gastrulation (Fog Our data support a model wherein Smog regulates distinct myosin pools and actin cytoskeleton in a ligand-dependent
- Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior...
A major pan-receptor focus has been to identify GPCR-selective ligands that have bias in G protein-dependent this field has exploded during the past two decades, it is only recently that highly β-arrestin biased ligands
- From Pipettes to Platforms: The Evolution of GPCR Research
Just her, radioactive ligands, and steady hands. could make or break the result, The pace and precision of GPCR research today — from high-throughput ligand
- 📰 GPCR Weekly News, May 20 to 26, 2024
differentiation through ERK activation GPCR Binders, Drugs, and more Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists Development of Putative Bivalent Dicovalent Ligands proteomics reveals CLR interactome in primary human cells Exploiting Cell-Based Assays to Accelerate Drug Development pathophysiological perspectives Structural and Molecular Insights into GPCR Function Bilayer lipids modulate ligand
- 📰 GPCR Weekly News, March 4 to 10, 2024
whole-genome SNP-based analysis Industry News Boehringer Ingelheim and Sosei Heptares join forces to develop Deciphering the role of GPCRs in obesity pathology for drug development GPCR Events, Meetings, and Webinars March 13 - 15 | Biologics 2024 March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating
- 📰 GPCR Weekly News, November 6 to November 12, 2023
Healthcare Conference in London Sosei Heptares and Kallyope Nominate First GPCR Target for Therapeutic Development 2023 InterAx Biotech Announces Being the Recipient of a Highly Competitive European Grant to Fund Drug Development and Reports Financing Highlights Neurocrine Biosciences Provides Development Pipeline Update Crinetics Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Biophysics Post-Doctoral Associate Team Leader Antibody Discovery Staff Scientist (AC-TAP) in Database Development
- Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors
Crystal structures suggest ligand access to the orthosteric binding site of MT1 and MT2 receptors through significantly different in the two receptor subtypes, as assessed by metadynamics simulations, and during ligand of connecting the orthosteric binding site and the membrane core for lipophilic melatonin receptor ligands pocket on the surface of MT1 receptor, which could participate in the recognition of MT1-selective ligands
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
Sometimes when you’re in the field you forget the importance GPCRs holds in drug development as a whole She gave us an overview of the drugs she has participated in developing throughout her career, highlighting Xiaoyu Zhang showed great insight into new ligands for new E3 ligases for PROTAC development.
- 📰 GPCR Weekly News, February 6 to 12, 2023
Isoform- and ligand-specific modulation of the adhesion GPCR ADGRL3/Latrophilin3 by a synthetic binder Development and Characterization of a Highly Selective Turn-On Fluorescent Ligand for β3-Adrenergic Receptor Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. GPCR Jobs Director, Business Development & Strategy CADD and Informatics Head or Team Lead (depending PhD student at Department of Drug Design and Pharmacology Software / database development postdoc at
- 📰 GPCR Weekly News, May 15 to 21, 2023
GPCR Activation and Signaling Monitoring the Reversibility of GPCR Signaling by Combining Photochromic Ligands GPCRs in Neuroscience Conformationally Selective 2-Aminotetralin Ligands Targeting the alpha2A- and alpha2C-Adrenergic Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.









